• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估遗传信息治理模式的视角:平衡公平、效率与可持续性

A Lens for Evaluating Genetic Information Governance Models: Balancing Equity, Efficiency and Sustainability.

作者信息

Skorve Espen, Vassilakopoulou Polyxeni, Aanestad Margunn, Grünfeld Thomas

机构信息

Aalborg University, Denmark.

University of Agder, Norway.

出版信息

Stud Health Technol Inform. 2017;235:298-302.

PMID:28423802
Abstract

This paper draws from the literature on collective action and the governance of the commons to address the governance of genetic data on variants of specific genes. Specifically, the data arrangements under study relate to the BRCA genes (BRCA1 and BRCA2) which are linked to breast and ovarian cancer. These data are stored in global genetic data repositories and accessed by researchers and clinicians, from both public and private institutions. The current BRCA data arrangements are fragmented and politicized as there are multiple tensions around data ownership and sharing. Three key principles are proposed for forming and evaluating data governance arrangements in the field. These principles are: equity, efficiency and sustainability.

摘要

本文借鉴了关于集体行动和公地治理的文献,以探讨特定基因变异的遗传数据治理问题。具体而言,所研究的数据安排涉及与乳腺癌和卵巢癌相关的BRCA基因(BRCA1和BRCA2)。这些数据存储在全球遗传数据存储库中,供公立和私立机构的研究人员和临床医生使用。当前的BRCA数据安排分散且政治化,因为在数据所有权和共享方面存在多重矛盾。本文提出了该领域数据治理安排的形成和评估的三项关键原则。这些原则是:公平、效率和可持续性。

相似文献

1
A Lens for Evaluating Genetic Information Governance Models: Balancing Equity, Efficiency and Sustainability.评估遗传信息治理模式的视角:平衡公平、效率与可持续性
Stud Health Technol Inform. 2017;235:298-302.
2
BRCA screening.BRCA基因检测
Med Lett Drugs Ther. 2007 Nov 19;49(1274):93-4.
3
Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and/or ovarian cancer.对BRCA1和BRCA2基因进行新一代测序,用于遗传性乳腺癌和/或卵巢癌的基因诊断。
J Mol Diagn. 2015 Mar;17(2):162-70. doi: 10.1016/j.jmoldx.2014.11.004. Epub 2014 Dec 31.
4
BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.乳腺癌和卵巢癌综合征中的BRCA1和BRCA2突变:对克里顿大学高危家族历史系列的思考。
Fam Cancer. 2006;5(1):15-20. doi: 10.1007/s10689-005-2571-7.
5
Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families.突尼斯乳腺癌/卵巢癌家族中BRCA1/BRCA2突变状态的家族史预测因素
Breast Cancer. 2017 Mar;24(2):238-244. doi: 10.1007/s12282-016-0693-4. Epub 2016 Mar 30.
6
Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.在阿什肯纳兹族乳腺癌和卵巢癌家族中未发现基因组 BRCA1 和 BRCA2 重排。
Breast Cancer Res Treat. 2010 Sep;123(2):581-5. doi: 10.1007/s10549-010-0818-y. Epub 2010 Mar 11.
7
Cost effectiveness analysis of genetic testing for breast and ovarian cancer susceptibility genes: BRCA1 and BRCA2.乳腺癌和卵巢癌易感基因BRCA1和BRCA2基因检测的成本效益分析
Breast J. 2014 May-Jun;20(3):325-6. doi: 10.1111/tbj.12269. Epub 2014 Apr 8.
8
Variability in Cancer Risk with BRCA Mutations.携带BRCA基因突变的癌症风险变异性。
Cancer Discov. 2015 Jul;5(7):OF16. doi: 10.1158/2159-8290.CD-NB2015-063. Epub 2015 May 7.
9
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.意大利乳腺癌和/或卵巢癌家族中新型BRCA1和BRCA2种系突变以及突变谱和患病率评估
Breast Cancer Res Treat. 2006 Nov;100(1):83-91. doi: 10.1007/s10549-006-9225-9. Epub 2006 May 9.
10
Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.德国南部乳腺癌和/或卵巢癌家族中23种新的BRCA1和BRCA2基因序列改变
Hum Mutat. 2003 Sep;22(3):259. doi: 10.1002/humu.9174.